KAS
SLS icon

Kestra Advisory Services’s SELLAS Life Sciences SLS Stock Holding History

Kestra Advisory Services’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$516K Buy
34,980
+5,830
+20% +$40.2K ﹤0.01% 2321
2026
Q1 		$123K Buy
29,150
+1,750
+6% +$7.83K ﹤0.01% 3008
2025
Q4 		$103K Buy
27,400
+1,000
+4% +$1.94K ﹤0.01% 3393
2025
Q3 		$42.5K Buy
+26,400
New +$47K ﹤0.01% 2867

Other funds holding SLS

DI
DAGCO Inc Westlake, Ohio $541M AUM 29.31% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
FWA
Fulcrum Wealth Advisors Bellevue, Washington $131M AUM
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
IW
Instrumental Wealth Tampa, Florida $198M AUM 24.07% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return
VH
Visionary Horizons Knoxville, Tennessee $239M AUM 22.35% 1-Year Est. Return
NAMP
NorthStar Asset Management (Pennsylvania) Blue Bell, Pennsylvania $531M AUM 27.28% 1-Year Est. Return
FD
Financial Designs Claremont, California $187M AUM 14.59% 1-Year Est. Return

Kestra Advisory Services's SLS Position: Q2 2026 in Review

Kestra Advisory Services increased its SELLAS Life Sciences (SLS) stake by 20% in Q2 2026, buying an estimated $40.2K and bringing the position to 34,980 shares worth $516K. The position accounts for ﹤0.01% of the portfolio, ranked #2321.

Kestra Advisory Services first reported a position in SLS in Q3 2025 and has held it in 4 quarters since. 37 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Kestra Advisory Services held 34,980 shares of SELLAS Life Sciences worth $516K as of Q2 2026.
  • Kestra Advisory Services bought 5,830 SELLAS Life Sciences shares in Q2 2026, an estimated $40.2K.
  • SELLAS Life Sciences made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #2321 holding.
  • Kestra Advisory Services first reported a position in SELLAS Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • 37 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.